Jacobs Levy Equity Management Inc. Acquires New Holdings in LifeStance Health Group, Inc. $LFST

Jacobs Levy Equity Management Inc. acquired a new stake in LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 1,190,954 shares of the company's stock, valued at approximately $7,932,000. Jacobs Levy Equity Management Inc. owned about 0.31% of LifeStance Health Group at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also added to or reduced their stakes in LFST. Parcion Private Wealth LLC bought a new position in LifeStance Health Group in the 1st quarter valued at approximately $15,670,000. Nuveen LLC bought a new position in LifeStance Health Group in the 1st quarter valued at approximately $6,928,000. Landscape Capital Management L.L.C. bought a new position in LifeStance Health Group in the 1st quarter valued at approximately $5,135,000. Vanguard Group Inc. lifted its stake in LifeStance Health Group by 5.0% in the 1st quarter. Vanguard Group Inc. now owns 11,221,237 shares of the company's stock valued at $74,733,000 after purchasing an additional 531,841 shares during the last quarter. Finally, Wellington Management Group LLP lifted its stake in LifeStance Health Group by 9.2% in the 4th quarter. Wellington Management Group LLP now owns 5,276,237 shares of the company's stock valued at $38,886,000 after purchasing an additional 445,796 shares during the last quarter. Institutional investors own 85.50% of the company's stock.

LifeStance Health Group Price Performance

Shares of NASDAQ LFST opened at $5.37 on Monday. LifeStance Health Group, Inc. has a twelve month low of $3.74 and a twelve month high of $8.61. The firm has a fifty day simple moving average of $4.77 and a 200 day simple moving average of $5.80. The company has a market capitalization of $2.09 billion, a PE ratio of -107.40 and a beta of 1.17. The company has a quick ratio of 1.48, a current ratio of 1.48 and a debt-to-equity ratio of 0.19.

LifeStance Health Group (NASDAQ:LFST - Get Free Report) last announced its earnings results on Thursday, August 7th. The company reported ($0.01) earnings per share for the quarter, topping analysts' consensus estimates of ($0.03) by $0.02. LifeStance Health Group had a negative net margin of 1.23% and a negative return on equity of 1.11%. The business had revenue of $345.31 million during the quarter, compared to the consensus estimate of $345.05 million. During the same quarter last year, the firm earned ($0.06) earnings per share. LifeStance Health Group's quarterly revenue was up 10.6% on a year-over-year basis. LifeStance Health Group has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. On average, sell-side analysts forecast that LifeStance Health Group, Inc. will post -0.18 EPS for the current year.

Analysts Set New Price Targets

Several equities analysts recently commented on the stock. BTIG Research assumed coverage on shares of LifeStance Health Group in a research note on Friday, July 25th. They issued a "buy" rating and a $8.00 price objective for the company. Wall Street Zen raised shares of LifeStance Health Group from a "hold" rating to a "buy" rating in a research note on Saturday, August 9th. Finally, UBS Group raised their price target on shares of LifeStance Health Group from $8.50 to $9.00 and gave the company a "buy" rating in a research note on Friday, August 8th. One research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $8.50.

Insider Buying and Selling

In related news, major shareholder Summit Partners L. P sold 8,407,643 shares of LifeStance Health Group stock in a transaction on Monday, August 18th. The shares were sold at an average price of $5.07, for a total transaction of $42,626,750.01. Following the completion of the transaction, the insider owned 33,524,715 shares of the company's stock, valued at $169,970,305.05. This trade represents a 20.05% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, major shareholder Silversmith Partners I. Gp, Llc sold 3,592,357 shares of LifeStance Health Group stock in a transaction on Monday, August 18th. The stock was sold at an average price of $5.07, for a total transaction of $18,213,249.99. Following the transaction, the insider directly owned 14,324,197 shares of the company's stock, valued at $72,623,678.79. This represents a 20.05% decrease in their position. The disclosure for this sale can be found here. Insiders sold 20,407,643 shares of company stock valued at $103,466,750 over the last quarter. Insiders own 6.60% of the company's stock.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.